Evercore ISI Group analyst Liisa Bayko downgrades BioCryst Pharmaceuticals (NASDAQ:BCRX) from Outperform to In-Line and announces $14 price target.
ETF Winners And Losers: Micro-Cap Returns – Volatility In The Market Spikes SPIKES Futures
We performed a screening of small-cap ETFs, defined as having Assets Under Management (AUM) below $400 million - to determine what funds had the largest positive and negative returns on the week, according to data from etfdb.com. Only non-leveraged funds were considered.
